<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Quantum Discovery Labs &#187; inflammation</title>
	<atom:link href="http://q-pharm.com/category/inflammation/feed/" rel="self" type="application/rss+xml" />
	<link>http://q-pharm.com</link>
	<description>The drug discovery company</description>
	<lastBuildDate>Fri, 02 Mar 2012 06:38:21 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Application of a novel in silico high throughput screen to identify selective inhibitors for protein–protein interactions</title>
		<link>http://q-pharm.com/2010/08/application-of-a-novel-in-silico-high-throughput-screen-to-identify-selective-inhibitors-for-protein%e2%80%93protein-interactions/</link>
		<comments>http://q-pharm.com/2010/08/application-of-a-novel-in-silico-high-throughput-screen-to-identify-selective-inhibitors-for-protein%e2%80%93protein-interactions/#comments</comments>
		<pubDate>Thu, 05 Aug 2010 15:05:38 +0000</pubDate>
		<dc:creator>Peter Fedichev, Quantum CTO</dc:creator>
				<category><![CDATA[docking]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[Quantum Software]]></category>
		<category><![CDATA[selectivity]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=334</guid>
		<description><![CDATA[Increasing numbers of target protein structures available for computational studies makes the structure-based screening paradigm more attractive for initial hit indentification. We have developed a novel in silico screening methodology...
Related posts:<ol>
<li><a href='http://q-pharm.com/2008/06/quantum-pharmaceuticals-announce-collaboration-with-university-of-colorado-at-boulder/' rel='bookmark' title='Quantum announce collaboration with University of Colorado at Boulder'>Quantum announce collaboration with University of Colorado at Boulder</a></li>
<li><a href='http://q-pharm.com/2012/01/high-throughput-screening-of-transcription-factor-dlx5/' rel='bookmark' title='High Throughput Screening of Transcription factor DLX5'>High Throughput Screening of Transcription factor DLX5</a></li>
<li><a href='http://q-pharm.com/quantum-discovery-services/virtual-high-throughput-screening/' rel='bookmark' title='Virtual High Throughput Screening'>Virtual High Throughput Screening</a></li>
<li><a href='http://q-pharm.com/2010/02/drug-discovery-identifying-potential-therapeutics-that-inhibit-opioids-induced-glial-cell-activation/' rel='bookmark' title='Drug Discovery: identifying potential therapeutics that inhibit opioids-induced glial cell activation'>Drug Discovery: identifying potential therapeutics that inhibit opioids-induced glial cell activation</a></li>
<li><a href='http://q-pharm.com/2011/04/influenza-matrix-m1-protein-inhibitors-show-promising-in-vivo-efficacy/' rel='bookmark' title='Influenza matrix M1 protein inhibitors show promising in-vivo efficacy'>Influenza matrix M1 protein inhibitors show promising in-vivo efficacy</a></li>
</ol>]]></description>
		<wfw:commentRss>http://q-pharm.com/2010/08/application-of-a-novel-in-silico-high-throughput-screen-to-identify-selective-inhibitors-for-protein%e2%80%93protein-interactions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug Discovery: identifying potential therapeutics that inhibit opioids-induced glial cell activation</title>
		<link>http://q-pharm.com/2010/02/drug-discovery-identifying-potential-therapeutics-that-inhibit-opioids-induced-glial-cell-activation/</link>
		<comments>http://q-pharm.com/2010/02/drug-discovery-identifying-potential-therapeutics-that-inhibit-opioids-induced-glial-cell-activation/#comments</comments>
		<pubDate>Fri, 05 Feb 2010 11:19:49 +0000</pubDate>
		<dc:creator>Peter Fedichev, Quantum CTO</dc:creator>
				<category><![CDATA[collaboration]]></category>
		<category><![CDATA[drug design]]></category>
		<category><![CDATA[inflammation]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=187</guid>
		<description><![CDATA[Pain remains a significant public health issue with two-thirds of patients achieving little to no pain relief from the myriad of currently available pharmacotherapies and dosing regimens. The use of...
No related posts.]]></description>
		<wfw:commentRss>http://q-pharm.com/2010/02/drug-discovery-identifying-potential-therapeutics-that-inhibit-opioids-induced-glial-cell-activation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quantum announce collaboration with University of Colorado at Boulder</title>
		<link>http://q-pharm.com/2008/06/quantum-pharmaceuticals-announce-collaboration-with-university-of-colorado-at-boulder/</link>
		<comments>http://q-pharm.com/2008/06/quantum-pharmaceuticals-announce-collaboration-with-university-of-colorado-at-boulder/#comments</comments>
		<pubDate>Sun, 15 Jun 2008 15:11:00 +0000</pubDate>
		<dc:creator>businessdev</dc:creator>
				<category><![CDATA[collaboration]]></category>
		<category><![CDATA[inflammation]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=32</guid>
		<description><![CDATA[Moscow, July 15 2008 Quantum  announce drug discovery collaboration with University of Colorado at Boulder. Under the terms of agreement Quantum will apply its state-of-the-art in-house drug discovery technology to...
Related posts:<ol>
<li><a href='http://q-pharm.com/2007/08/quantum-pharmaceuticals-and-molecmo-nanobiotechnologies-announce-collaboration/' rel='bookmark' title='Quantum and MOLECMO Nanobiotechnologies announce collaboration.'>Quantum and MOLECMO Nanobiotechnologies announce collaboration.</a></li>
<li><a href='http://q-pharm.com/2008/10/quantum-pharmaceuticals-collaborates-with-university-of-pittsburgh-on-hiv-drug-discovery/' rel='bookmark' title='Quantum collaborates with University of Pittsburgh on HIV drug discovery.'>Quantum collaborates with University of Pittsburgh on HIV drug discovery.</a></li>
<li><a href='http://q-pharm.com/2006/06/quantum-pharmaceuticals-and-institute-of-pulmonology-entered-copd-drug-discovery-collaboration/' rel='bookmark' title='Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.'>Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.</a></li>
<li><a href='http://q-pharm.com/2006/10/hiv-1-integrase-drug-discovery-collaboration/' rel='bookmark' title='HIV-1 integrase drug discovery collaboration'>HIV-1 integrase drug discovery collaboration</a></li>
<li><a href='http://q-pharm.com/2008/10/quantum-pharmaceuticals-enters-collaboration-with-childrens-cancer-institute-australia/' rel='bookmark' title='Quantum enters collaboration with Children&#8217;s Cancer Institute Australia'>Quantum enters collaboration with Children&#8217;s Cancer Institute Australia</a></li>
</ol>]]></description>
		<wfw:commentRss>http://q-pharm.com/2008/06/quantum-pharmaceuticals-announce-collaboration-with-university-of-colorado-at-boulder/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

